Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Respiration Disorders

• Study to Evaluate the AIO-001 in Healthy Participants
• RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
• Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
• Total Intravenous Anesthesia for Rigid Bronchoscopy Using Remimazolam
• Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
• Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2
• Supportive Treatment and Antibiotics for Mild Pediatric Pneumonia
• Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
• Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
• SOLIDARITY Finland Plus Long COVID-19
• Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)
• LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
• NAC for Attenuation of COVID-19 Symptomatology
• Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19
• Mechanisms of Dupilumab in AERD
• Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients
• Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
• Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
• Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
• Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19
• Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
• Dupilumab in CRSsNP (Liberty CRSsNP ORION)
• Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decli
• LYT-100 in Post-acute COVID-19 Respiratory Disease
• A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease
• The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
• Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19
• Effect of Dupilumab on Aspirin Intolerance
• Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
• Inhaled Ibuprofen to Treat COVID-19
• Protective Role of Inhaled Steroids for Covid-19 Infection
• Daily Vitamin D for Sickle-cell Respiratory Complications
• Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients With CRS
• HDDO-1801 Intervention Trial
• Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD
• Screening for Cancer in Patients With Thromboembolic Disease
• The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases
• Non-specific Effects of Rabies Vaccine
• Dupilumab for Aspirin-exacerbated Respiratory Disease
• Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at Altitude
• A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
• Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
• A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults
• Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
• A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis
• A Study of Oral Hymecromone and Hyaluronan Synthesis
• What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
• Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
• Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
• Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration
• Dexamethasone and Respiratory Function After Mastectomy
• Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults
• Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
• Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
• In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstructio
• The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases
• A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers
• Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
• Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057
• Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal
• Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.
• Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
• Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
• Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
• Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e)
• Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis
• Prophylactic Efficacy of Relenza Against Influenza A and B
• Use of Dexmedetomidine to Facilitate Extubation in Surgical ICU Patients Who Failed Previous Weaning Attempts
• Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
• A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
• Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy